Form D — Invea Therapeutics, Inc
0001906425-25-000004 · filed 2025-12-10
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $120,250
- Total sold
- $120,250
- Minimum investment
- $10,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Invea Therapeutics, Inc
- CIK
- 1906425
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 2614 BOSTON POST ROAD, SUITE 33B
GUILFORD, CT 06437 - Phone
- (203) 643-8002
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Krishnan Nandabalan · Executive OfficerGuilford, CT Find on LinkedIn ↗
-
Aman Kant · Executive OfficerGuilford, CT Find on LinkedIn ↗
-
Michael J. Aiello · Executive OfficerGuilford, CT Find on LinkedIn ↗
-
Salvatore Alesci · Executive OfficerGuilford, CT Find on LinkedIn ↗
-
Shunichiro "Steve" Okada · Executive OfficerGuilford, CT Find on LinkedIn ↗
-
Kerrie Brady · DirectorGuilford, CT Find on LinkedIn ↗
-
Stephen Doberstein · DirectorGuilford, CT Find on LinkedIn ↗
-
Demetrios Kydonieus · DirectorGuilford, CT Find on LinkedIn ↗
-
Jonathan Zalevsky · DirectorGuilford, CT Find on LinkedIn ↗
View original on SEC EDGAR.